Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Unknown 5Completed 5Recruiting 4Terminated 2Not yet recruiting 2Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 8Neoplasm Metastasis 2Advanced Breast Cancer 2Prostatic Neoplasms 1Melanoma 1HER2-positive Breast Cancer 1Exanthema 1Diarrhea 1Brest Cancer 1Breast Cancer Metastatic 1Advanced/Metastatic Solid Tumors 1

Interventions

Injections 2Fulvestrant 2trastuzumab deruxtecan 1toripalimab 1palbociclib 1dalpiciclib 1Sirolimus 1Paclitaxel 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Advanced Breast Cancer × Fulvestrant × Clear all
NCT07619066 2026-06-01

AGATHA

MedSIR

Phase 2 Not yet recruiting
25 enrolled
Breast

Advanced Breast Cancer

NCT06941142 2025-04-23

A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 1 Not yet recruiting
382 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡